This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Sep 10;26(26):4359; author reply 4359-60.

doi: 10.1200/JCO.2008.18.4440.

Pseudoprogression in glioblastoma

Marc C Chamberlain

PMID: 18779626
DOI: 10.1200/JCO.2008.18.4440

Comment

Pseudoprogression in glioblastoma

Marc C Chamberlain. J Clin Oncol. 2008.

. 2008 Sep 10;26(26):4359; author reply 4359-60.

doi: 10.1200/JCO.2008.18.4440.

Author

Marc C Chamberlain

PMID: 18779626
DOI: 10.1200/JCO.2008.18.4440

No abstract available

PubMed Disclaimer

Comment on

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M. Brandes AA, et al. J Clin Oncol. 2008 May 1;26(13):2192-7. doi: 10.1200/JCO.2007.14.8163. J Clin Oncol. 2008. PMID: 18445844

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.